LIP
AXSM icon

Lighthouse Investment Partners’s Axsome Therapeutics AXSM Stock Holding History

Lighthouse Investment Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
10,427
+8,878
+573% +$1.93M 0.07% 325
2026
Q1 		$262K Sell
1,549
-3,091
-67% -$534K 0.01% 609
2025
Q4 		$847K Buy
+4,640
New +$648K 0.03% 517
2024
Q1 		– Sell
-56,202
Closed -$4.47M – 378
2023
Q4 		$4.47M Buy
+56,202
New +$3.76M 0.2% 117

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Lighthouse Investment Partners's AXSM Position: Q2 2026 in Review

Lighthouse Investment Partners increased its Axsome Therapeutics (AXSM) stake by 573% in Q2 2026, buying an estimated $1.93M and bringing the position to 10,427 shares worth $2.55M. The position accounts for 0.07% of the portfolio, ranked #325.

Lighthouse Investment Partners first reported a position in AXSM in Q4 2023 and has held it in 4 quarters since. The position peaked at $4.47M in Q4 2023. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Lighthouse Investment Partners held 10,427 shares of Axsome Therapeutics worth $2.55M as of Q2 2026.
  • Lighthouse Investment Partners bought 8,878 Axsome Therapeutics shares in Q2 2026, an estimated $1.93M.
  • Axsome Therapeutics made up 0.07% of Lighthouse Investment Partners's portfolio in Q2 2026, its #325 holding.
  • Lighthouse Investment Partners first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Lighthouse Investment Partners's Axsome Therapeutics position peaked at $4.47M in Q4 2023.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.